Neubase Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Neubase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neubase Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neubase Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $8.5k | 19k | 0.45 |
| 2023-12-31 | $14k | 19k | 0.74 |
| 2023-09-30 | $17k | 19k | 0.87 |
| 2023-06-30 | $36k | 19k | 1.87 |